Analyst reiterated coverage of Apple with a rating of Overweight and set a new price target of $230.00 from $245.00 previously
Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/2/2025 | $188.32 | Underperform → Hold | Jefferies |
| 6/26/2025 | $245.00 → $230.00 | Overweight | Analyst |
| 6/4/2025 | Buy → Hold | Needham | |
| 5/2/2025 | $290.00 → $275.00 | Buy | TD Cowen |
| 5/2/2025 | $217.00 | Buy → Neutral | Rosenblatt |
| 5/2/2025 | $170.62 | Hold → Underperform | Jefferies |
| 5/2/2025 | $260.00 → $245.00 | Buy | Monness Crespi & Hardt |
| 4/30/2025 | $197.00 → $173.00 | Underweight | Barclays |
For Immediate Release: September 17, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued a draft guidance, “Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice,” which, when finalized, will support the conduct of randomized controlled trials with streamlined protocols a
For Immediate Release: September 12, 2024 Today, the U.S. Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature, intended to be used with compatible versions of the Apple AirPods Pro headphones. Once installed and customized to the user’s hearing needs, the Hearing Aid Feature enables compatible versions of the AirPods Pro to serve as an OTC hea
Tune in to Apple Music Radio for a broadcast celebration with hosts Zane Lowe, Ebro Darden, and special guests as they reminisce about their favorite moments from the past 10 years while looking toward the future As Apple Music® marks its 10th anniversary this year, Apple® unveils its most ambitious creative project to date: a brand-new state-of-the-art studio space in Los Angeles dedicated to artist-driven content, innovation in audio, and deeper fan connection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250630314776/en/Apple unveils a brand-new state-of-the-art studio space in Los Angeles dedicated to artist-driven conte
908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Christopher D. Brown, PhD, Vice President, Analytics R&D at Repligen Corporation (NASDAQ:RGEN), and a 908 Devices Co-founder, to serve on its Board of Directors, effective immediately. Dr. Brown co-founded 908 Devices and served as the company's Chief Technology Officer & Vice President of Research & Development from February 2012 to March 2023, and as its Chief Product Officer from March 2023 until March 2025 when Repligen purchased the company's bioprocessing portfolio. Prior to 908 Devices, Dr. Brown was a platform architect at Apple Inc. (NASDAQ:AAPL) lead
Access to the on-device Apple Intelligence model, large language model integration in Xcode, and an elegant new software design across Apple platforms give developers everything they need to build beautiful modern apps with speed and confidence Apple® today announced new technologies and enhancements to its developer tools to help developers create more beautiful, intelligent, and engaging app experiences across Apple platforms. A beautiful new software design brings more focus to content, and delivers more expressive and delightful experiences across iOS 26, iPadOS® 26, macOS® Tahoe 26, watchOS® 26, and tvOS® 26,1 while keeping them all instantly familiar. The Foundation Models framework
908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Christopher D. Brown, PhD, Vice President, Analytics R&D at Repligen Corporation (NASDAQ:RGEN), and a 908 Devices Co-founder, to serve on its Board of Directors, effective immediately. Dr. Brown co-founded 908 Devices and served as the company's Chief Technology Officer & Vice President of Research & Development from February 2012 to March 2023, and as its Chief Product Officer from March 2023 until March 2025 when Repligen purchased the company's bioprocessing portfolio. Prior to 908 Devices, Dr. Brown was a platform architect at Apple Inc. (NASDAQ:AAPL) lead
The company is also expanding the coed Apple Foundation Program to enhance learning opportunities for more students at the Apple Developer Academy Apple® today announced plans to expand in the Kingdom of Saudi Arabia, starting with the launch of the Apple Store® online in summer 2025. The online store will bring customers across Saudi Arabia new ways to shop Apple's full range of products, with exceptional service and support directly from Apple in Arabic for the very first time. Starting in 2026, Apple will begin opening the first of several flagship Apple Store locations in Saudi Arabia. These retail stores will offer customers in the country even more ways to connect with Apple's kno
tvOS 18 introduces new cinematic experiences with InSight, Enhance Dialogue, and subtitles Apple® today announced software updates across its Home products that supercharge entertainment and deliver greater everyday convenience. With tvOS® 18, intelligent new features like InSight — and updates to Enhance Dialogue and subtitles — level up cinematic experiences, while new Apple Fitness+℠, Apple Music®, and FaceTime® capabilities get even better on users' biggest screen. The Home app gains new features with iOS 18, like guest access and hands-free unlock with home keys, delivering effortless and secure access to the home. tvOS 18 and iOS 18 are available as developer betas today, and will b
8-K - Apple Inc. (0000320193) (Filer)
FWP - Apple Inc. (0000320193) (Subject)
10-Q - Apple Inc. (0000320193) (Filer)
Services revenue reaches new all-time high EPS sets March quarter record Apple® today announced financial results for its fiscal 2025 second quarter ended March 29, 2025. The Company posted quarterly revenue of $95.4 billion, up 5 percent year over year, and quarterly diluted earnings per share of $1.65, up 8 percent year over year. "Today Apple is reporting strong quarterly results, including double-digit growth in Services," said Tim Cook, Apple's CEO. "We were happy to welcome iPhone 16e to our lineup, and to introduce powerful new Macs and iPads that take advantage of the extraordinary capabilities of Apple silicon. And we were proud to announce that we've cut our carbon emissions by
Product to separate the equity and dividend components of a stock and pass-through voting rights Permuto Capital LLC (Permuto), a joint venture between 3V Capital Partners SE LLC (3V Capital Partners) and Chia Network Inc. (Chia), today announced that two additional voting trust investment vehicles (each, a Trust) formed by Permuto have filed registration statements with the Securities and Exchange Commission (SEC) relating to proposed public offerings of a new type of equity product. Permuto will act as the trust administrator of the Trusts. Additionally, Permuto announced submission of a first amended registration statement for a MSFT Trust filed on January 15, 2025. The new products
All-time records for total company revenue and EPS Services revenue reaches new all-time high Apple® today announced financial results for its fiscal 2025 first quarter ended December 28, 2024. The Company posted quarterly revenue of $124.3 billion, up 4 percent year over year, and quarterly diluted earnings per share of $2.40, up 10 percent year over year. "Today Apple is reporting our best quarter ever, with revenue of $124.3 billion, up 4 percent from a year ago," said Tim Cook, Apple's CEO. "We were thrilled to bring customers our best-ever lineup of products and services during the holiday season. Through the power of Apple silicon, we're unlocking new possibilities for our users
4 - Apple Inc. (0000320193) (Issuer)
4 - Apple Inc. (0000320193) (Issuer)
4 - Apple Inc. (0000320193) (Issuer)
Jefferies upgraded Apple from Underperform to Hold and set a new price target of $188.32
Analyst reiterated coverage of Apple with a rating of Overweight and set a new price target of $230.00 from $245.00 previously
Needham downgraded Apple from Buy to Hold
SC 13G/A - Apple Inc. (0000320193) (Subject)
SC 13G/A - Apple Inc. (0000320193) (Subject)
SC 13G/A - Apple Inc. (0000320193) (Subject)